Status:
UNKNOWN
Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est
Lead Sponsor:
Centre Hospitalier Intercommunal Robert Ballanger
Collaborating Sponsors:
Groupe Hospitalier Pitie-Salpetriere
Conditions:
COVID
SARS-CoV 2
Eligibility:
All Genders
Brief Summary
Healthcare centers treated several hundreds of patients with Covid-19 and prospectively gathered information in electronic format between March, 2020 to April, 2020. In the course of Covid-19 treatmen...
Detailed Description
Healthcare centers treated several hundreds of patients with Covid-19 and prospectively gathered information in electronic format between March, 2020 to April, 2020. In the course of Covid-19 treatmen...
Eligibility Criteria
Inclusion
- hospitalized for Covid-19
- severe pneumonia defined as pulse O2 \< 96% despite \> 6L/min
Exclusion
- lack of consent
- palliative care patients
- patients in ICU
- patients transferred from ICU
Key Trial Info
Start Date :
March 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04366206
Start Date
March 14 2020
End Date
July 31 2020
Last Update
April 28 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Intercommunal Robert Ballanger
Aulnay-sous-Bois, France, 93600
2
Groupe Hospitalier Pitie Salpetriere
Paris, France, 75013